{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:27:42Z","timestamp":1790954862378,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07828"],"award-info":[{"award-number":["20K07828"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["MO20K16529"],"award-info":[{"award-number":["MO20K16529"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00392-022-02023-0","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:04:27Z","timestamp":1650341067000},"page":"1104-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Decreases in hepatokine Fetuin-A levels are associated with hepatic hypoperfusion and predict cardiac outcomes in patients with heart failure"],"prefix":"10.1007","volume":"111","author":[{"given":"Yusuke","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4795-9334","authenticated-orcid":false,"given":"Tomofumi","family":"Misaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiomi","family":"Yoshihisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yamadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himika","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hotsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"2023_CR1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, E.S.C.S.D. Group (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"2023_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","volume":"62","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, Mullens W (2013) Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 62:485\u2013495","journal-title":"J Am Coll Cardiol"},{"key":"2023_CR3","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S M\u00f8ller","year":"2013","unstructured":"M\u00f8ller S, Bernardi M (2013) Interactions of the heart and the liver. Eur Heart J 34:2804\u20132811","journal-title":"Eur Heart J"},{"key":"2023_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","volume":"34","author":"M Nikolaou","year":"2013","unstructured":"Nikolaou M, Parissis J, Yilmaz MB, Seronde MF, Kivikko M, Laribi S, Paugam-Burtz C, Cai D, Pohjanjousi P, Laterre PF, Deye N, Poder P, Cohen-Solal A, Mebazaa A (2013) Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J 34:742\u2013749","journal-title":"Eur Heart J"},{"key":"2023_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK (2019) The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev 40:1367\u20131393","journal-title":"Endocr Rev"},{"key":"2023_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ (2017) Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol 13:509\u2013520","journal-title":"Nat Rev Endocrinol"},{"key":"2023_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ijo.2014.203","volume":"39","author":"JF Trepanowski","year":"2015","unstructured":"Trepanowski JF, Mey J, Varady KA (2015) Fetuin-A: a novel link between obesity and related complications. Int J Obes (Lond) 39:734\u2013741","journal-title":"Int J Obes (Lond)"},{"key":"2023_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.ki.5002178","volume":"72","author":"MM Hermans","year":"2007","unstructured":"Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW, D. Netherlands cooperative study on the adequacy of 2007 (2007) Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72:202\u2013207","journal-title":"Kidney Int"},{"key":"2023_CR9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.2009090944","volume":"21","author":"T Hamano","year":"2010","unstructured":"Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998\u20132007","journal-title":"J Am Soc Nephrol"},{"key":"2023_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, E.S.C.S.D. Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"2023_CR11","doi-asserted-by":"publisher","first-page":"e016689","DOI":"10.1161\/JAHA.120.016689","volume":"9","author":"A Yoshihisa","year":"2020","unstructured":"Yoshihisa A, Ishibashi S, Matsuda M, Yamadera Y, Ichijo Y, Sato Y, Yokokawa T, Misaka T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Takeishi Y (2020) Clinical implications of hepatic hemodynamic evaluation by abdominal ultrasonographic imaging in patients with heart failure. J Am Heart Assoc 9:e016689","journal-title":"J Am Heart Assoc"},{"key":"2023_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","volume":"50","author":"T Toshima","year":"2015","unstructured":"Toshima T, Shirabe K, Ikegami T, Yoshizumi T, Kuno A, Togayachi A, Gotoh M, Narimatsu H, Korenaga M, Mizokami M, Nishie A, Aishima S, Maehara Y (2015) A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol 50:76\u201384","journal-title":"J Gastroenterol"},{"key":"2023_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jjcc.2010.09.004","volume":"57","author":"N Shiba","year":"2011","unstructured":"Shiba N, Shimokawa H (2011) Chronic kidney disease and heart failure\u2013bidirectional close link and common therapeutic goal. J Cardiol 57:8\u201317","journal-title":"J Cardiol"},{"key":"2023_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nm.4326","volume":"23","author":"K Fujiu","year":"2017","unstructured":"Fujiu K, Shibata M, Nakayama Y, Ogata F, Matsumoto S, Noshita K, Iwami S, Nakae S, Komuro I, Nagai R, Manabe I (2017) A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation. Nat Med 23:611\u2013622","journal-title":"Nat Med"},{"key":"2023_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","volume":"7","author":"A Xanthopoulos","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F (2019) Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail 7:87\u201397","journal-title":"JACC Heart Fail"},{"key":"2023_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","volume":"12","author":"H Misu","year":"2010","unstructured":"Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T, Sakurai M, Yamashita T, Mizukoshi E, Yamashita T, Honda M, Miyamoto K, Kubota T, Kubota N, Kadowaki T, Kim HJ, Lee IK, Minokoshi Y, Saito Y, Takahashi K, Yamada Y, Takakura N, Kaneko S (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12:483\u2013495","journal-title":"Cell Metab"},{"key":"2023_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"N Stefan","year":"2013","unstructured":"Stefan N, Haring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144\u2013152","journal-title":"Nat Rev Endocrinol"},{"key":"2023_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/hep.22123","volume":"47","author":"KK Lai","year":"2008","unstructured":"Lai KK, Kolippakkam D, Beretta L (2008) Comprehensive and quantitative proteome profiling of the mouse liver and plasma. Hepatology 47:1043\u20131051","journal-title":"Hepatology"},{"key":"2023_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20100330","volume":"429","author":"S Dasgupta","year":"2010","unstructured":"Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, Bhattacharya S (2010) NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J 429:451\u2013462","journal-title":"Biochem J"},{"key":"2023_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","volume":"89","author":"B Vollmar","year":"2009","unstructured":"Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89:1269\u20131339","journal-title":"Physiol Rev"},{"key":"2023_CR21","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2337\/dc12-1870","volume":"36","author":"GA Laughlin","year":"2013","unstructured":"Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH (2013) Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study. Diabetes Care 36:1994\u20132000","journal-title":"Diabetes Care"},{"key":"2023_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2337\/dc11-1267","volume":"35","author":"M Bluher","year":"2012","unstructured":"Bluher M, Rudich A, Kloting N, Golan R, Henkin Y, Rubin E, Schwarzfuchs D, Gepner Y, Stampfer MJ, Fiedler M, Thiery J, Stumvoll M, Shai I (2012) Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35:342\u2013349","journal-title":"Diabetes Care"},{"key":"2023_CR23","doi-asserted-by":"publisher","first-page":"E130","DOI":"10.1152\/ajpendo.00158.2021","volume":"321","author":"ED Abel","year":"2021","unstructured":"Abel ED (2021) Insulin signaling in the heart. Am J Physiol Endocrinol Metab 321:E130\u2013E145","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023_CR24","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1161\/CIRCULATIONAHA.108.814418","volume":"118","author":"C Weikert","year":"2008","unstructured":"Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555\u20132562","journal-title":"Circulation"},{"key":"2023_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2009.05.018","volume":"207","author":"K Rittig","year":"2009","unstructured":"Rittig K, Thamer C, Haupt A, Machann J, Peter A, Balletshofer B, Fritsche A, Haring HU, Stefan N (2009) High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis 207:341\u2013342","journal-title":"Atherosclerosis"},{"key":"2023_CR26","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2011.08.035","volume":"58","author":"JH Ix","year":"2011","unstructured":"Ix JH, Barrett-Connor E, Wassel CL, Cummins K, Bergstrom J, Daniels LB, Laughlin GA (2011) The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo study. J Am Coll Cardiol 58:2372\u20132379","journal-title":"J Am Coll Cardiol"},{"key":"2023_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MCA.0b013e32832fe5d5","volume":"21","author":"K Mori","year":"2010","unstructured":"Mori K, Ikari Y, Jono S, Emoto M, Shioi A, Koyama H, Shoji T, Ishimura E, Inaba M, Hara K, Nishizawa Y (2010) Fetuin-A is associated with calcified coronary artery disease. Coron Artery Dis 21:281\u2013285","journal-title":"Coron Artery Dis"},{"key":"2023_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41467-020-20832-7","volume":"12","author":"S Rudloff","year":"2021","unstructured":"Rudloff S, Janot M, Rodriguez S, Dessalle K, Jahnen-Dechent W, Huynh-Do U (2021) Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress. Nat Commun 12:549","journal-title":"Nat Commun"},{"key":"2023_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM (2019) Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139:1289\u20131299","journal-title":"Circulation"},{"key":"2023_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","volume":"391","author":"PM Ridker","year":"2018","unstructured":"Ridker PM, Macfadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ, C.T. Group (2018) Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 391:319\u2013328","journal-title":"Lancet"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:12:02Z","timestamp":1664536322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02023-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Fukushima Medical University (approval number, 823), and was complied with the Declaration of Helsinki. All patients provided written informed consent for study participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}